LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.88 | 84.90 | 982 | 531 | 1.8493 | 1.5234 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.88 | 84.90 | 1163 | 531 | 2.1902 | 1.6901 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.58 | 84.90 | 36 | 663 | 0.0543 | -0.2512 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.58 | 84.90 | 1035 | 663 | 1.5601 | 1.3236 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.58 | 84.90 | 2 | 663 | 0.0030 | -0.7174 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 14.58 | 84.90 | 1253 | 663 | 1.8887 | 1.4782 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.29 | 84.90 | 78 | 766 | 0.1017 | -0.0263 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.29 | 84.90 | 1136 | 766 | 1.4814 | 1.2635 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.29 | 84.90 | 1 | 766 | 0.0013 | -0.7531 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 16.29 | 84.90 | 1333 | 766 | 1.7383 | 1.3804 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.99 | 84.90 | 105 | 898 | 0.1168 | 0.0644 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.99 | 84.90 | 1214 | 898 | 1.3504 | 1.1845 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.99 | 84.90 | 1 | 898 | 0.0011 | -0.7287 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.99 | 84.90 | 1456 | 898 | 1.6196 | 1.3043 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 19.69 | 84.90 | 344 | 1239 | 0.2776 | 0.4359 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 19.69 | 84.90 | 1312 | 1239 | 1.0586 | 1.0296 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 19.69 | 84.90 | 1 | 1239 | 0.0008 | -0.6828 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 19.69 | 84.90 | 1559 | 1239 | 1.2578 | 1.1222 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.40 | 84.90 | 582 | 1454 | 0.4001 | 0.5994 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.40 | 84.90 | 1423 | 1454 | 0.9782 | 0.9893 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.40 | 84.90 | 1 | 1454 | 0.0007 | -0.6616 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 21.40 | 84.90 | 1727 | 1454 | 1.1872 | 1.0855 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.10 | 84.90 | 667 | 1616 | 0.4127 | 0.6241 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.10 | 84.90 | 1514 | 1616 | 0.9368 | 0.9695 | MN20160318_Q02 | E06 |